Christopher Ntoumenopoulos

Christopher Ntoumenopoulos is a declared insider of Tryp Therapeutics Inc., with filings sourced from SEDI. The record holds 2 filings, for trades running from 16 May 2022 to 14 June 2022.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 19 June 2022, the filings show an option exercise worth €101k in Tryp Therapeutics Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.